Susquehanna International Group
LEGN icon

Susquehanna International Group’s Legend Biotech LEGN Stock Holding History

Susquehanna International Group’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.47M Buy
81,200
+36,600
+82% +$698K ﹤0.01% 6941
2025
Q4 		$970K Sell
44,600
-32,400
-42% -$928K ﹤0.01% 7265
2025
Q3 		$2.51M Buy
77,000
+68,900
+851% +$2.54M ﹤0.01% 5309
2025
Q2 		$287K Sell
8,100
-11,800
-59% -$382K ﹤0.01% 10436
2025
Q1 		$675K Buy
19,900
+9,400
+90% +$337K ﹤0.01% 8238
2024
Q4 		$342K Sell
10,500
-15,500
-60% -$642K ﹤0.01% 9549
2024
Q3 		$1.27M Sell
26,000
-38,500
-60% -$2.05M ﹤0.01% 6280
2024
Q2 		$2.86M Sell
64,500
-243,400
-79% -$11.2M ﹤0.01% 4413
2024
Q1 		$17.3M Buy
307,900
+135,300
+78% +$8.16M ﹤0.01% 1946
2023
Q4 		$10.4M Buy
172,600
+157,300
+1,028% +$9.97M ﹤0.01% 2602
2023
Q3 		$1.03M Sell
15,300
-60,700
-80% -$4.22M ﹤0.01% 6574
2023
Q2 		$5.25M Sell
76,000
-4,300
-5% -$281K ﹤0.01% 3451
2023
Q1 		$3.87M Sell
80,300
-119,800
-60% -$5.86M ﹤0.01% 3846
2022
Q4 		$9.99M Sell
200,100
-316,200
-61% -$15.3M ﹤0.01% 2285
2022
Q3 		$21.1M Buy
516,300
+296,500
+135% +$13.9M 0.01% 1386
2022
Q2 		$12.1M Buy
219,800
+79,200
+56% +$3.34M ﹤0.01% 1966
2022
Q1 		$5.11M Buy
140,600
+126,700
+912% +$5.01M ﹤0.01% 3610
2021
Q4 		$648K Sell
13,900
-15,400
-53% -$781K ﹤0.01% 8462
2021
Q3 		$1.48M Buy
29,300
+21,000
+253% +$874K ﹤0.01% 6516
2021
Q2 		$341K Buy
+8,300
New +$282K ﹤0.01% 10491

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
FBIL
First Beijing Investment Ltd Hong Kong $2.32B AUM 8.06% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group's LEGN Position: Q1 2026 in Review

Susquehanna International Group increased its Legend Biotech (LEGN) stake by 19% in Q1 2026, buying an estimated $555K and bringing the position to 182,364 shares worth $3.3M. The position accounts for ﹤0.01% of the portfolio, ranked #5072.

Susquehanna International Group first reported a position in LEGN in Q1 2021 and has held it in 16 quarters since. The position peaked at $8.74M in Q2 2025. 189 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

  • Susquehanna International Group held 182,364 shares of Legend Biotech worth $3.3M as of Q1 2026.
  • Susquehanna International Group bought 29,089 Legend Biotech shares in Q1 2026, an estimated $555K.
  • Legend Biotech made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #5072 holding.
  • Susquehanna International Group first reported a position in Legend Biotech in Q1 2021 and has held it in 16 quarters since.
  • Susquehanna International Group's Legend Biotech position peaked at $8.74M in Q2 2025.
  • 189 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.